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2Department of Chemistry, Katholieke Universiteit Leuven, Leuven, BelgiumABSTRACT Conformational selection is an established mechanism in molecular recognition. Despite its power to explain bind-
ing events, it is hardly used in protein/ligand design to modulate molecular recognition. Here, we explore the opportunities and
limitations of design by conformational selection. Using appropriate thermodynamic cycles, our approach predicts the effects of
a conformational shift on binding affinity and also allows one to disentangle the effects induced by a conformational shift from
other effects influencing the binding affinity. The method is assessed and applied to explain the contribution of a conformational
shift on the binding affinity of six ubiquitin mutants showing different conformational shifts in six different complexes.INTRODUCTIONConformational plasticity is indispensable for the function
of biomolecules. Conformational diversity allows a single
molecular machine to perform multiple functions, react
flexibly to signals (e.g., allosteric regulations), and permit
promiscuous molecular recognition (1–4). Conformational
plasticity is also most relevant for molecular evolution: sub-
states with minor populations might explore new functional-
ities, whereas the main function remains intact (5). It is clear
that distortions in or manipulations of the subtle conforma-
tional equilibria in biomolecular machines will alter their
functionality, e.g., ligand-binding affinity or enzymatic catal-
ysis. The populations of the substates can be modulated by
posttranslational modifications, changes in environment, by
mutations, or by binding of a second ligand. If delocalized
conformational changes are involved, these modifications
may be distant from the binding or active site, in which
case the induced conformational shift gives rise to allostery.
One of the most prominent roles for conformational plas-
ticity is in molecular recognition. The view is emerging that
conformational selection (6–9) plays a role in most binding
events. Because controlling molecular recognition is one of
the major challenges in the field of biophysical chemistry
(e.g., drug design, therapeutic proteins, understanding of
biological pathways), the question naturally arises if—and
to what extent—conformational selection can be exploited
for that purpose.
To that end, three strategies to control molecular recogni-
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0006-3495/15/05/2585/6 $2.00strategy is to optimize direct interactions between the pro-
tein and its binding partner, e.g., by introducing hydrogen
bonds, stacking interactions, etc. This strategy has been suc-
cessfully applied for the design of small molecules (10–12)
and in the design of proteins (13–15).
A second strategy is to reduce the loss of conformational
entropy upon binding by rigidifying binding partners. This
approach is well established in drug design (16) and has
also been used in protein-protein recognition (17), e.g.,
via introduction of disulfide bonds (18).
The concept of conformational selection suggests a third
strategy (19,20), outlined in Fig. 1 A. In this scenario, a
biomolecule in equilibrium can adopt different structural
conformations or substates, some of which are competent
to bind to a specific binding partner whereas others are
not. This property should enable control of both binding
and selectivity by stabilizing or destabilizing different
substates relative to the native biomolecule. Indeed,
several examples have been reported where the effect of
mutants was attributed to a change in the population of
the binding-competent substate of the equilibrium ensemble
(21–23). Although the concept of conformational prefer-
ences in the computation of free energies is well established
(20,24,25), we here provide a general picture describing the
effects of steering conformational preferences on binding
affinities in a conformational selection scenario.
Particularly, we will explore and quantify opportunities
and limitations in such a conformational selection-based
approach. To that aim, we will use a suitable thermody-
namic cycle (26) to predict how much the binding free
energy will change due to an introduced conformational
shift in different typical cases. Vice versa, this approach
should enable one to calculate what fraction of an
observed binding free-energy change can be attributed to
a change in substate populations, and thus to separatehttp://dx.doi.org/10.1016/j.bpj.2015.04.012
FIGURE 1 (A) Conformational selection-based
protein design. The native state of the protein has
an open and a closed conformational state (blue,
upper left), which are equally populated (light
gray shades). These can be selected by different
binding partners (dark gray). By modulating the
populations of the different states (denoted by the
color intensity of the symbols and the underlying
free-energy landscape) via mutations, selective
binding can be achieved. (B) Thermodynamic cy-
cle connecting the eight different states relevant
for conformational selection-controlled binding.
For explanation, see text. To see this figure in color,
go online.
2586 Michielssens et al.this effect from other, more direct effects such as enthalpic
interactions.
To assess the potential of conformational selection-
controlled molecular recognition, and to evaluate the ac-
curacy and predictive value of our approach, we will use
a comprehensive set of recently characterized mutations
that induce conformational shifts in ubiquitin (27). Ubiq-
uitin is an important signaling protein binding to a large
set of quite diverse receptors. The dominant recognition
mechanism is conformational selection, and the global dy-
namics of unbound ubiquitin captures all bound ubiquitin
structures (4). This dynamics is largely described by a sin-
gle collective motion, called the ‘‘pincer mode’’, between
an open and closed substate of ubiquitin. In most of the
ubiquitin complexes, the binding partner prefers binding
in either the open or the closed state (28), such that it
should be possible to change the binding affinity via
conformational shifts, which renders ubiquitin an excel-
lent test system. To that end, a set of calculated binding
free energies of six ubiquitin mutants with a known
conformational shift to six different binding partners
(27) will be considered.MATERIALS AND METHODS
Conformational selection-controlled binding
To define notation and to derive an expression for the binding free-energy
change DDG due to a conformational shift, we consider the thermodynamic
cycle (or cube, in this case) in Fig. 1 B. This cycle describes a protein that
binds to a ligand and occurs in two variants, denoted in Fig. 1 as native
(blue) and modified (red). The modification can be a mutation, a posttrans-
lational modification, allosteric changes, or any other effect. Each variant,
in turn, is assumed to adopt two different conformations, here denoted by
the terms ‘‘open’’ and ‘‘closed’’.
By definition, DDG is the difference between the ligand binding free en-
ergies DG of the modified protein and that of the native one, which reads in
terms of the respective partition functions Z,
DDG ¼ DGmodified  DGnative ¼ 1
b
ln
Zmodifiedbound Z
native
unbound
ZmodifiedunboundZ
native
bound
:
(1)
Here, b is the reciprocal thermal energy kBT. To obtain an easily interpret-
able expression for DDG, the following relevant free-energy differencesBiophysical Journal 108(10) 2585–2590are considered (see also Fig. 1 B): B is the binding affinity of the open
native state; C is the conformational free-energy difference between
open and closed unbound native states, which defines the relative popula-
tions of their conformational equilibrium; M is the free-energy change of
the open unbound state due to the modification; DB is the difference be-
tween the binding free energy of the closed native state and that of the
open native state; and DM is the change of the conformational free-energy
difference C due to the conformational shift induced by the protein
modification.
Note that, via the closure relation for the unbound states (upper-half of
Fig. 1 B), DM also denotes the difference between the free-energy change
M of the open unbound state due to the modification and that of the closed
unbound state.
Other than shifting conformational equilibria, the modification can also
modify the binding affinity more directly, e.g., by local interactions. Such
effects will be collected in the term DD and considered separately further
below.
With this notation, all free-energy differences marked by arrows are
readily expressed as indicated in Fig. 1 B in such a way that the respec-
tive closure relations are fulfilled, i.e., the sum over all closed paths is
zero. These expressions, in turn, allow us to expand all four partition
functions above, each of which is composed of two conformational
substates:
Znativeunbound ¼ e0 þ ebC;
Znativebound ¼ ebB þ ebðBþCþDBÞ;
Zmodifiedunbound ¼ ebM þ ebðMþCþDMÞ;
Zmodifiedbound ¼ ebðMþBþDDÞ þ ebðMþBþDDþCþDBþDMÞ:
Note that, without loss of generality, the absolute free energy of the native
open unbound state was set to zero.
With these four partition functions, the binding free-energy change DDG
reads
DDG ¼ DD 1
b
ln

1þ ebðCþDBþDMÞð1þ ebCÞ
ð1þ ebðCþDMÞÞð1þ ebðCþDBÞÞ: (2)
Notably, this expression is independent of the free-energy difference M
between native and modified protein, which canceled out. As should
be expected, DDG is composed of the direct effect of the modification
of binding affinity, DD, and a contribution due to the conformational
shift free energy, DM. We will subsequently focus on the latter,
but note that this fact allows one to separate DD from a set of deter-
mined affinities by comparing the (measured or calculated) total
change in free energy with the right-hand term in Eq. 2. The remain-
ing two relevant parameters are thus the free-energy difference C be-
tween native open and closed substates, and their differential binding
affinity DB.
Affinity Change by Conformational Shift 2587Simulations and calculations
Six different ubiquitin complexes studied in Michielssens et al. (27) were
considered; their structures were taken from the Protein Data Bank
(PDB) (29). Three of these complexes bind ubiquitin in the open substate
(Ubiquitin Carboxyl-terminal esterase L3 (UCH-L3, PDB:1XD3), Rab5
GDP/GTP exchange factor (PDB:2FIF), and the UBA domain of Dsk2
(PDB:4UN2), DB > 0). Two of them bind ubiquitin in the closed substate
(UBA domain of Dsk2 (PDB:1NBF) and Ubiquitin carboxyl-terminal hy-
drolase 5 (PDB:2G45), DB < 0). One has no preference for either of the
states (vacuolar protein sorting protein 36 (PDB:2HTH), DBz 0).
For each of these six complexes, binding free-energy changes DDG for
all six mutants were taken from previously determined binding free en-
ergies (27). Free-energy differences DM and C for these six mutations
were taken from previous alchemical calculations (27).
Neither experimental nor calculated binding affinity differences between
the open and closed native state were available; these were, therefore, calcu-
lated here from additional umbrella sampling molecular dynamics (MD)
simulations of free ubiquitin and of ubiquitin in the six different complexes.
DB was then determined from the difference between the free ubiquitin
conformational free-energy difference C (see Fig. 1 B) and that of the
respective complex, C þ DB.
All simulations were set up and carried out as described previously (27).
For the umbrella sampling, the pincer mode (collective mode describing
the open-closing motion) identified previously (4) was used as a reaction
coordinate. Twenty-one umbrella windows were used. The minima of the
windows were placed at equidistant positions along this collective coordi-
nate between 1.0 and 0.5 nm. The initial structure for each umbrella
simulation was selected as the structure closest to the respective umbrella
potential minimum from a free MD simulation of the complex. Note that
in three of the complexes (PDB:1XD3, PDB:1NBF, and PDB:2FIF), ubiq-
uitin explores only either the open or the closed state. In those cases the
essential dynamics module of GROMACS (30,31) using fixed step linear
expansion was used to generate starting structures for the umbrella sam-
pling simulations (32,33). A force constant of 1000 kJ/(mol nm2) was
applied, using the pincer mode as a reaction coordinate. For each of
the umbrella windows, 10 simulations of 120 ns each were performed,
each starting from different velocities chosen from a Maxwell distribution.
To eliminate initial relaxation effects, only the last 100 ns of each
simulation were used for subsequent analysis. The total simulation
time for umbrella sampling simulations was 25.2 ms. The free-energy
profile was determined using WHAM (34), and the error was estimated
using Bayesian bootstrapping of complete histograms as implemented in
G_WHAM (35).
Using the above free-energy differences, the expected contributions of
conformational selection to the binding free-energy changes were calcu-
lated from Eq. 2.RESULTS AND DISCUSSION
Conformational selection-controlled binding
Fig. 2 illustrates the effect of C and DB on DDG as a
function of conformational shift free-energy DM. We will
restrict our discussion to the upper part of Fig. 2 (C % 0);
the lower part (C < 0) is related by symmetry and is shown
to provide the full picture and serves as an orientation for the
reader.
For C % 0, four scenarios can be distinguished: First, if
the binding-competent state forms a major population (red-
dish curves), the potential to improve the binding affinity is
limited. However, a significant destabilization of the com-
plex can be achieved by relative stabilization of the bind-ing-incompetent state, by maximally jCj þ jDBj. Second,
in contrast, if the binding-competent state forms a minor
population (blue and green curves), significant affinity gains
by up to maximum (jDBj, jCj) can be reached by relative sta-
bilization of the binding-competent state. As a typical case,
consider, e.g., a dominant open state with preferred binding
to the closed state. In this case, already a shift of 10 kJ/mol
(blue curves) changes the binding affinity from the micro-
molar to the nanomolar range. Destabilization of up to
maximum (jDBj  jCj, 0) can be achieved by a conforma-
tional shift toward the binding-incompetent conformation.
This limit is reached if jDMj and jCj compensate for jDBj.
If, third, the binding-competent and incompetent states
have similar populations, no large gain in binding affinity
is expected. Rather, more selective binding can be achieved
by a conformational shift that exclusively populates one of
the conformations. Fourth, if both states have similar affin-
ities, no affinity or selectivity change can be induced by a
conformational shift. Hence, DBs 0 is a necessary condi-
tion for a conformational shift strategy to affect binding
affinity.Application to ubiquitin binding
Six mutations in ubiquitin were considered (Fig. 3), the
conformational free-energy shifts DM (dashed lines, see
also Fig. 1 B) of which have been previously calculated
from MD simulations (27). As can be seen, two of the mu-
tations shift the conformational equilibrium of the unbound
state toward the closed state (L69S, L69T, DM < 0), two
others toward the open state (I13F, I36A, DM > 0), and
the remaining two do not largely affect the conformational
equilibrium (V5L, I36L, DM z 0).
The colored lines in Fig. 3 quantify the expected binding
free-energy changes DDG according to Eq. 2 for each of the
six ubiquitin complexes as a function of the conformational
free-energy shift DM. The respective intersections with the
dashed lines, therefore, denote the binding free-energy
changes for each of the mutations, as predicted by our
conformational selection framework. Because the free-en-
ergy difference C between the open and closed states of
free ubiquitin is only 1.7 kJ/mol, both the open and the
closed state are expected to be similarly populated. Accord-
ingly, the third case of small C considered above applies, for
which the binding-competent state is already relatively
abundant for both the open- and closed-state-preferring
binding partners. Therefore, the potential to increase the
binding strength is limited.
These six predicted binding free-energy changes are
compared in Fig. 4 to those calculated previously from
alchemical calculations. Because the former only describe
the contribution of conformational selection to the total
binding free energies, no full agreement (black diagonal)
is expected; nevertheless, over the entire dataset an average
unsigned deviation of only 3.85 kJ/mol is obtained.Biophysical Journal 108(10) 2585–2590
FIGURE 2 Various scenarios for the effect of a
conformational shift by mutation on the binding af-
finity DDG as discussed in the text. The plots differ
by the population of the native state equilibria
(described by C). In each plot, the different curves
(colors) describe binding preference DB to the
open (DB > 0) or closed (DB < 0) state. To see
this figure in color, go online.
2588 Michielssens et al.Remarkably, the predicted values correlate well with the
calculated data with a correlation coefficient of 0.56 (N ¼
36).
On average, the binding free-energy changes predicted
from a pure conformational selection scenario (black diag-
onal in Fig. 4) are smaller than the calculated ones by a fac-
tor of five (blue linear fit). To assess the significance of this
deviation, we considered two factors.
The first factor is that there is a statistical uncertainty in
both the direct calculation of DDG and the calculation of
DDG via the conformational shift. Considering the resultingFIGURE 3 Predicted binding free-energy changes DDG (colored lines)
due to six different ubiquitin mutants in six different complexes. (Dashed
lines) Calculated conformational free-energy shifts DM for six point mu-
tants (27). To see this figure in color, go online.
Biophysical Journal 108(10) 2585–2590error bars (obtained by bootstrapping, see the Supporting
Material), 75% of all mutations in all complexes are within
2 SDs from the binding affinities expected from the confor-
mational shifts alone. If this were the only effect, and
assuming a Gaussian error distribution, one would expect
95% of all results to fall within this interval. This indicates
that the statistical uncertainty alone is not sufficient to
explain the observed differences. Additionally, we expect
that, due to insufficient sampling, our alchemical calcula-
tions tend to overestimate the mutation-induced destabiliza-
tion of protein-protein complexes in those cases where theFIGURE 4 Comparison between predicted and calculated binding free-
energy changes. (Black solid line) Perfect agreement; (blue line) linear
regression fit. To see this figure in color, go online.
Affinity Change by Conformational Shift 2589free-energy minimum of the mutant is separated from that of
the native state by a slow structural transition. The L69T
ubiquitin mutant in complex with the dsk2 protein is one
such example, where it was found that the experimental
destabilization due to the mutation was markedly lower
than the calculated value (27).
The second factor suggests an interesting application of
our analysis, namely that additional effects can be quantified
via their effect on DDG. If all required parameters as well as
the observed effect on DDG are at hand, Eq. 2 can be used to
separate the effect caused by a conformational shift from
other factors via DD. Although the mutations were inten-
tionally introduced in the hydrophobic core of ubiquitin to
minimize direct effects on DDG, these cannot be fully ruled
out. If this analysis were correct, and because DD enters into
Eq. 2 only as an offset, any direct effects should decrease
with increasing distance of the mutation site from the bind-
ing interface.
This idea is tested in Fig. 5, which shows DD, estimated
from the differences between predicted and calculated free-
energy shifts DDG, as a function of the distance of the
respective mutation from the binding site (also listed in
Fig. 5). Indeed, the estimated DD values systematically
decrease with increasing distance. The largest jDDj values
are seen for mutations close to the binding interface
(3.38–6.75 A˚) (L69S-1NBF, L69T-1NBF, L69T-2G45,
I36L-1XD3, and L69T-2HTH), where only a small effect
is predicted but significant destabilization (>1 kcal/mol)
is observed. Also, the mutation I36A-1NBF should destabi-
lize the complex, but no significant effect is observed.
In contrast, for mutations where the distance is larger
than 8 A˚ (15 mutations), an average unsigned error
of 1.5 kJ/mol and a correlation coefficient of 0.72 is
obtained. Notably, for the distant mutations, 87% of theFIGURE 5 Deviation (symbols) between predicted binding free-energy
changes (based on the conformational shift) and calculated changes from
alchemical mutational free-energy changes in complexes (27) as a function
of the distance from the binding interface. (Solid line) Linear regression fit.predicted binding free-energy changes fall within the 95%
confidence interval, corroborating that these deviations
can be largely explained by the statistical uncertainty of
the free-energy calculations. For these cases, therefore,
direct effects seem to be small.
For free ubiquitin, the free-energy difference C between
the open and closed states was found to be small and
hence, the potential for enhancing affinities is small, in
agreement with the binding free energies found in the six
mutations in the six complexes. For other cases, where
the binding-competent state is sparsely populated, larger
affinity gains are expected. Further, according to our anal-
ysis, a substantial increase of binding selectivity for
ubiquitin should be possible by reducing the binding
strength, thus shifting the equilibrium toward the bind-
ing-incompatible conformation. This direct connection
between conformational selection-controlled affinity and
selectivity is a feature that may be useful for pharmacolog-
ical applications.
We have developed a quantitative method to predict the
effect of a mutation-induced conformational shift on bind-
ing affinity via conformational selection. This method can
serve to guide an emerging protein design strategy where
protein-protein binding is optimized using conformational
shifts. Within this framework, binding affinity changes are
predicted quantitatively if substate populations in the
wild-type, and preference for a given substate of the
binding partner, are known. The framework can further
be used to determine what fraction of the change in
binding free energy (DDG) is due to conformational shift,
and thus can be disentangled from other, direct binding
interactions.
The method was tested against a dataset of six ubiquitin
mutants with known conformational shifts and known
preferences for the involved conformational substates. The
observed effects were found to agree well with our
predictions.
This work characterizes the opportunities and limitations
of modulating conformational equilibria to control biomol-
ecular properties. Although the focus here was mainly on
exploring the effect due to mutations, our method is quite
general and thus serves to rationalize the effects of confor-
mational modulations on allosteric regulation, posttransla-
tional modifications, or environmental changes.SUPPORTING MATERIAL
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